Delivery Order SPE2DB22D2206-SPE2DB24FHV48

Award Date 6/20/24
Potential Completion Date 6/21/24
Potential Value $30K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4564658757 INFUVITE ADULT VIAL 10ML pharmaceutical products, with a ceiling value of $3,732.17. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, on May 20, 2024, with an ultimate completion date of May 21, 2024. This is a Firm Fixed Price Delivery Order contract, with no set-aside designation used. Amerisourcebergen Drug Corp, a major supplier of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $59,659.19 firm fixed-price delivery order is for the supply of INFUVITE ADULT VIAL 10ML medical products, with a performance period ending on May 16, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,461.41, is a Firm Fixed Price Delivery Order for the supply of INFUVITE ADULT VIAL 10ML medical products. The contract has a period of performance through June 24, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a $10,191.98 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of INFUVITE ADULT VIAL 10ML medical products. The contract has an ultimate completion date of May 27, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of INFUVITE ADULT VIAL 10ML medical products. The contract has a firm fixed price of $3,551.67 and a period of performance through June 24, 2025. Amerisourcebergen Drug Corp is a for-profit organization that has held a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,999.46 firm fixed-price delivery order is for the supply of 4568250414 - INFUVITE ADULT VIAL 10ML, with a performance period through May 15, 2025. The contract is not set-aside and represents open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,126.15 Firm Fixed Price delivery order contract is for the supply of INFUVITE ADULT VIAL 10ML medical products. The contract has an ultimate completion date of May 2, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $8,803.89 Firm Fixed Price Delivery Order is for the supply of INFUVITE ADULT VIAL 10ML, a pharmaceutical product, with an ultimate completion date of May 10, 2024. Amerisourcebergen Drug Corp's Corporate Office Division holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to...
This federal contract award, valued at $19,198.79, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of INFUVITE ADULT BULK VIAL 100ML, a pharmaceutical product, with a period of performance through May 15, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
This federal contract award is for the delivery of InfuVite Adult Vial 10ML pharmaceutical products to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The $3,546.56 Firm Fixed Price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies globally. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FHV48
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of INFUVITE ADULT BULK VIAL 100ML pharmaceutical products. The $29,529.66 firm fixed price contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of June 21, 2024.

Amerisourcebergen, a major pharmaceutical distributor, holds two Indefinite Delivery Contracts (IDCs) with the DLA and Department of Justice Federal Bureau of Investigation, collectively valued up to $1,749,999,999.00, to provide a wide range of pharmaceutical products and medical supplies to support federal healthcare programs and the U.S. Armed Forces globally. This specific delivery order was awarded without a set-aside designation, indicating Amerisourcebergen's strong competitive position in the federal pharmaceutical supply market.

Generated 9/19/24, 9:48 AM